FibroGen
FGEN
FGEN
68 hedge funds and large institutions have $19.2M invested in FibroGen in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 70 → 68 (-2)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
33% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 21
Holders
68
Holding in Top 10
1
Calls
$336K
Puts
$84K
Top Buyers
| 1 | +$321K | |
| 2 | +$234K | |
| 3 | +$205K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$91K |
| 5 |
Two Sigma Advisers
New York
|
+$71.8K |
Top Sellers
| 1 | -$2.8M | |
| 2 | -$873K | |
| 3 | -$842K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$438K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$220K |